Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cytopenia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Motor Activity 200 Breast Neoplasms 116 Neoplasms 82 Prostatic Neoplasms 32 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

ON 01910 2 Biopsy 2 AP 1903 reagent 2 thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 Specimen Handling 1 Sertraline 1 Pluvicto 1 Peripheral Blood Stem Cell Transplantation 1 Metformin 1 Interleukin-8 1 IDO-1 inhibitor LY3381916 1 HuMax-IL8 1 Granulocyte Colony-Stimulating Factor 1 Genetic Counseling 1 Filgrastim 1 Exercise 1 Emapalumab 1 Decitabine 1 DNA 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773871 2025-08-19

HemEx

Rigshospitalet, Denmark

Phase NA Recruiting

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡